Solaris Pharma Receives FDA Approval for Generic Metrogel-Vaginal®
October 27, 2021 08:00 ET
|
Solaris Pharma Corporation
-- Current annual market for Metrogel-Vaginal totals $62 million – -- Metronidazole vaginal gel 0.75% to launch immediately -- BRIDGEWATER, N.J., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma...
Solaris Pharma Receives Approval for First Generic Version of Clindagel® (clindamycin phosphate EQ 1%)
August 23, 2021 08:00 ET
|
Solaris Pharma Corporation
BRIDGEWATER, N.J., Aug. 23, 2021 (GLOBE NEWSWIRE) -- Solaris Pharma Corporation (“Solaris” or the “Company”) announced today that the Company has received an abbreviated new drug application...